We are live on
!
Find out more
TCM
Trybe Capital Management Portfolio holdings
AUM
$1.09B
1-Year Est. Return
249.75%
This Fund
S&P 500
This Quarter
Est. Return
-3.5%
1 Year Est. Return
+249.75%
3 Year Est. Return
+680.91%
5 Year Est. Return
+833.26%
10 Year Est. Return
–
AUM
$104M
AUM Growth
-$43.3M
(-29%)
Cap. Flow
-$10.3M
Cap. Flow
% of AUM
-9.91%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
13
New
1
Increased
–
Reduced
9
Closed
3
Avg Time Held Equity + Options
6.5
quarters
Top 10 Avg Time Held Equity + Options
5.8
quarters
Top 20 Avg Time Held Equity + Options
6.5
quarters
Avg Time Held Equity only
7.2
quarters
Top 10 Avg Time Held Equity only
6.9
quarters
Top 20 Avg Time Held Equity only
7.2
quarters
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ginkgo Bioworks
DNA
|
+$3.29M |
| 2 |
Apple
AAPL
|
+$1.88M |
| 3 |
NVIDIA
NVDA
|
+$791K |
| 4 |
ServiceNow
NOW
|
+$667K |
| 5 |
Microsoft
MSFT
|
+$647K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 59.24% |
| 2 | Miscellaneous | 18.12% |
| 3 | Communication Services | 14.28% |
| 4 | Consumer Discretionary | 8.37% |
| 5 | Healthcare | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
CALL
NVIDIA
NVDA
$5.72T
| $18.9M | 18.12% |
+1,290,000
| New | +$18.9M |
2022 Q4
0 quarters
|
|
|
2
Microsoft
MSFT
$3.91T
| $13.2M | 12.71% |
55,144
-2,694
| -5% | -$647K |
2020 Q4
8 quarters
|
|
|
3
Apple
AAPL
$4.87T
| $12.9M | 12.44% |
99,615
-13,160
| -12% | -$1.88M |
2020 Q4
8 quarters
|
|
4
Alphabet (Google) Class A
GOOGL
$4.22T
| $11.4M | 10.98% |
129,452
-6,336
| -5% | -$602K |
2020 Q4
8 quarters
|
|
|
5
NVIDIA
NVDA
$5.72T
| $11.4M | 10.96% |
780,680
-53,920
| -6% | -$791K |
2020 Q4
8 quarters
|
|
|
6
ServiceNow
NOW
$141B
| $10.5M | 10.12% |
135,640
-8,530
| -6% | -$667K |
2020 Q4
8 quarters
|
|
7
Amazon
AMZN
$2.72T
| $8.71M | 8.37% |
103,705
-5,547
| -5% | -$548K |
2020 Q4
8 quarters
|
|
8
Salesforce
CRM
$189B
| $7.81M | 7.5% |
58,893
-4,265
| -7% | -$622K |
2020 Q4
8 quarters
|
|
9
Marvell Technology
MRVL
$245B
| $5.72M | 5.5% |
154,475
-15,827
| -9% | -$646K |
2021 Q3
5 quarters
|
|
10
Roblox
RBLX
$31.5B
| $3.43M | 3.3% |
120,648
-17,513
| -13% | -$615K |
2021 Q4
4 quarters
|
|
|
11
Ginkgo Bioworks
DNA
$976M
| – | – |
-26,359
| Closed | -$3.29M | – |
|
12
CALL
Newmont
NEM
$122B
| – | – |
-955,300
| Closed | -$40.2M | – |
|
|
13
CALL
Roblox
RBLX
$31.5B
| – | – |
-200,000
| Closed | -$7.17M | – |
|
Similar funds
AA
LEA
RA
AAIM
CFFNO
IF
APC
SAM
Trybe Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Trybe Capital Management held 13 positions worth $104M, down 29% from $147M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trybe Capital Management withdrew a net $10.3M in Q4 2022, closing 3 positions and reducing 9 holdings. Its most notable exit was Ginkgo Bioworks, an estimated $3.29M position sold in full.
By sector, the portfolio is most concentrated in Technology at 59% of assets, up from 45% a quarter earlier, followed by Miscellaneous and Communication Services.
- Trybe Capital Management's biggest Q4 2022 reduction was Apple, cutting an estimated $1.88M.
- Trybe Capital Management fully exited Ginkgo Bioworks in Q4 2022, selling an estimated $3.29M.
- Trybe Capital Management's ten largest holdings make up 100% of its $104M portfolio in Q4 2022.
- Trybe Capital Management opened 1 new position and closed 3 in Q4 2022.
- Trybe Capital Management's portfolio value fell 29% quarter-over-quarter to $104M.
Based on Trybe Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.